378 related articles for article (PubMed ID: 8339265)
1. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
3. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
[TBL] [Abstract][Full Text] [Related]
4. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.
Oyama T; Kanai Y; Ochiai A; Akimoto S; Oda T; Yanagihara K; Nagafuchi A; Tsukita S; Shibamoto S; Ito F
Cancer Res; 1994 Dec; 54(23):6282-7. PubMed ID: 7954478
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the cadherin-catenin cell adhesion system in cancers.
Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S
Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063
[TBL] [Abstract][Full Text] [Related]
6. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
7. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
[TBL] [Abstract][Full Text] [Related]
8. Cadherin switching in human prostate cancer progression.
Tomita K; van Bokhoven A; van Leenders GJ; Ruijter ET; Jansen CF; Bussemakers MJ; Schalken JA
Cancer Res; 2000 Jul; 60(13):3650-4. PubMed ID: 10910081
[TBL] [Abstract][Full Text] [Related]
9. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
Tomita K; van Bokhoven A; Jansen CF; Bussemakers MJ; Schalken JA
Biochem Biophys Res Commun; 2000 Jan; 267(3):870-4. PubMed ID: 10673383
[TBL] [Abstract][Full Text] [Related]
10. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.
Shimoyama Y; Nagafuchi A; Fujita S; Gotoh M; Takeichi M; Tsukita S; Hirohashi S
Cancer Res; 1992 Oct; 52(20):5770-4. PubMed ID: 1394201
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin mediated adhesion system in cancer cells.
Shiozaki H; Oka H; Inoue M; Tamura S; Monden M
Cancer; 1996 Apr; 77(8 Suppl):1605-13. PubMed ID: 8608551
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers.
Hirohashi S
Verh Dtsch Ges Pathol; 2000; 84():28-32. PubMed ID: 11217445
[TBL] [Abstract][Full Text] [Related]
13. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.
Davies G; Jiang WG; Mason MD
J Urol; 2000 Mar; 163(3):985-92. PubMed ID: 10688036
[TBL] [Abstract][Full Text] [Related]
14. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
15. Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells.
Vermeulen SJ; Bruyneel EA; Bracke ME; De Bruyne GK; Vennekens KM; Vleminckx KL; Berx GJ; van Roy FM; Mareel MM
Cancer Res; 1995 Oct; 55(20):4722-8. PubMed ID: 7553655
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
Hiscox S; Jiang WG
Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the cadherin-catenin complex in normal human thyroid epithelium and a thyroid carcinoma cell line.
Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
J Cell Biochem; 1998 Sep; 70(3):330-7. PubMed ID: 9706870
[TBL] [Abstract][Full Text] [Related]
18. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
[TBL] [Abstract][Full Text] [Related]
19. Cadherin and catenin alterations in human cancer.
Hajra KM; Fearon ER
Genes Chromosomes Cancer; 2002 Jul; 34(3):255-68. PubMed ID: 12007186
[TBL] [Abstract][Full Text] [Related]
20. Leuprorelin acetate affects adhesion molecule expression in human prostate cancer cells.
Angelucci C; Lama G; Iacopino F; Sica G
Int J Oncol; 2011 Jun; 38(6):1501-9. PubMed ID: 21479359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
